世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

活性型止血剤の世界市場インサイト、2029年までの予測


Global Active Hemostatic Agents Market Insights, Forecast to 2029

活性止血剤は、手術面からの出血を管理するための標準的な手術手技である。活性止血剤は様々な手術現場で使用されており、このクラスの手術器具の進化は、現在の外科や泌尿器科における活性止血剤の進歩に役立ち... もっと見る

　

　

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ 		2023年11月22日 US$4,900
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら 		英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


　

サマリー

活性止血剤は、手術面からの出血を管理するための標準的な手術手技である。活性止血剤は様々な手術現場で使用されており、このクラスの手術器具の進化は、現在の外科や泌尿器科における活性止血剤の進歩に役立ち、将来の研究の機会を浮き彫りにする。
世界の活性止血剤市場は、COVID-19とロシア・ウクライナ戦争の二重の影響を受けた2022年の100万米ドルに比べ、2023年には％のプラス成長で100万米ドルに達すると予想される。川下産業からの需要増加を背景に、活性止血剤産業は2029年に百万米ドルに達すると評価されている。2023年から2029年までのCAGRは％である。

当社の調査によると、医療機器の世界市場は2023年に6,030億米ドルと推定され、今後6年間のCAGRは5％で成長する。世界の医療支出は世界GDPの10%を占め、高齢化による健康ニーズの増加、慢性疾患や感染症の流行、新興市場の拡大により、近年増加し続けています。医療機器市場は、ヘルスケア産業において重要な役割を果たしている。この市場を牽引しているのは、世界的な高度医療サービスに対する需要の高まり、医療技術の進歩、高齢者人口の増加、医療費の増加、病気の早期診断・治療に対する意識の高まりなど、いくつかの要因である。

レポートの対象
本レポートは、2018年から2029年までの世界の活性型止血剤市場の概観を紹介し、読者が世界の活性型止血剤市場を多角的に包括的に理解することを目的としています。2018年から2029年までの地域別売上高、収益、2018年から2023年までのメーカーの売上高、価格、収益、粗利益率などの項目を分析しています。さらに、2018年から2029年までの各地域における製品タイプおよび用途の売上高と収益も強調しています。

レポートに掲載されているメーカー、タイプ、アプリケーション、地域
企業別
ファイザー
バクスターインターナショナル
CryoLife Inc.
Integra Life Sciences Corporation など
ストライカー
バイオムアップ
BD
ジョンソン・エンド・ジョンソン サービス
C.R.バード
B.ブラウン・メルサンゲンAG
Z-Medica LLC
アドバンスド・メディカル・ソリューションズ・グループ plc
ゲリータGA
活性止血剤
ウォリアー・タクティカル
タイプ別セグメント
トロンビンベースの止血剤
外科用シーラント
コンビネーション製品
用途別セグメント
病院
外来手術センター
専門クリニック
地域別セグメント
米国およびカナダ
米国
カナダ
中国
アジア（中国を除く）
日本
韓国
中国 台湾
東南アジア
インド
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
ラテンアメリカ、中東、アフリカ
ブラジル
メキシコ
トルコ
イスラエル
GCC諸国

章の概要
第1章：製品の定義、種類、用途の紹介
第2章：2018年から2029年までの地域別収益および販売量分析
第3章：メーカーの売上高、収益および価格分析、メーカーの活性型止血剤の工場分布、活性型止血剤の商業日、提供される製品タイプ、M&Aおよび拡大活動を含む。
第4章：2018年から2029年までの世界のタイプ別製品売上高、収益、価格分析
第5章：2018年から2029年までの世界的な用途別製品売上高、収益および価格分析
第6章：米国・カナダにおける2018年から2029年までのタイプ別・用途別製品売上高、収益分析2018年から2029年までの米国＆カナダにおける各国別製品売上高、収益分析
第7章：ヨーロッパにおける2018年から2029年までの製品の販売、タイプ別および用途別収益分析。2018年から2029年までの欧州各国の製品売上高、収益分析
第8章：2018年から2029年までの中国における製品の売上高、タイプ別および用途別の収益分析。2018年から2029年までの中国の製品売上高、収益分析
第9章：2018年から2029年までのアジア（中国を除く）における製品売上高、タイプ別および用途別収益分析。2018年から2029年までのアジア（中国を除く）各国の製品売上高、収益分析
第10章：2018年から2029年までの中東、アフリカ、ラテンアメリカにおける製品の販売、タイプ別および用途別収益分析。2018年から2029年までの中東、アフリカ、ラテンアメリカの各国における製品売上高、収益分析。
第11章：メーカーの概要、企業の基本情報、主要事業、活性型止血剤の紹介などをカバーしています。2018年から2023年までの各社の活性型止血剤の売上高、収益、価格、およびグロスマージン
第12章：原材料、製造コストのような産業チェーン分析。市場チャネル、流通業者、顧客分析
第13章：市場機会と課題分析
第14章：QYResearchによる活性型止血剤の結論
第15章：QYResearchが採用した方法論とデータソース


ページTOPに戻る


目次

1 Study Coverage
1.1 Active Hemostatic Agents Product Introduction
1.2 Market by Type
1.2.1 Global Active Hemostatic Agents Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Thrombin based hemostats
1.2.3 Surgical Sealants
1.2.4 Combination Products
1.3 Market by Application
1.3.1 Global Active Hemostatic Agents Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Specialty Clinics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Active Hemostatic Agents Sales Estimates and Forecasts 2018-2029
2.2 Global Active Hemostatic Agents Revenue by Region
2.2.1 Global Active Hemostatic Agents Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Active Hemostatic Agents Revenue by Region (2018-2023)
2.2.3 Global Active Hemostatic Agents Revenue by Region (2024-2029)
2.2.4 Global Active Hemostatic Agents Revenue Market Share by Region (2018-2029)
2.3 Global Active Hemostatic Agents Sales Estimates and Forecasts 2018-2029
2.4 Global Active Hemostatic Agents Sales by Region
2.4.1 Global Active Hemostatic Agents Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Active Hemostatic Agents Sales by Region (2018-2023)
2.4.3 Global Active Hemostatic Agents Sales by Region (2024-2029)
2.4.4 Global Active Hemostatic Agents Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Active Hemostatic Agents Sales by Manufacturers
3.1.1 Global Active Hemostatic Agents Sales by Manufacturers (2018-2023)
3.1.2 Global Active Hemostatic Agents Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Active Hemostatic Agents in 2022
3.2 Global Active Hemostatic Agents Revenue by Manufacturers
3.2.1 Global Active Hemostatic Agents Revenue by Manufacturers (2018-2023)
3.2.2 Global Active Hemostatic Agents Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Active Hemostatic Agents Revenue in 2022
3.3 Global Key Players of Active Hemostatic Agents, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Active Hemostatic Agents Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Active Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Active Hemostatic Agents, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Active Hemostatic Agents, Product Offered and Application
3.8 Global Key Manufacturers of Active Hemostatic Agents, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Active Hemostatic Agents Sales by Type
4.1.1 Global Active Hemostatic Agents Historical Sales by Type (2018-2023)
4.1.2 Global Active Hemostatic Agents Forecasted Sales by Type (2024-2029)
4.1.3 Global Active Hemostatic Agents Sales Market Share by Type (2018-2029)
4.2 Global Active Hemostatic Agents Revenue by Type
4.2.1 Global Active Hemostatic Agents Historical Revenue by Type (2018-2023)
4.2.2 Global Active Hemostatic Agents Forecasted Revenue by Type (2024-2029)
4.2.3 Global Active Hemostatic Agents Revenue Market Share by Type (2018-2029)
4.3 Global Active Hemostatic Agents Price by Type
4.3.1 Global Active Hemostatic Agents Price by Type (2018-2023)
4.3.2 Global Active Hemostatic Agents Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Active Hemostatic Agents Sales by Application
5.1.1 Global Active Hemostatic Agents Historical Sales by Application (2018-2023)
5.1.2 Global Active Hemostatic Agents Forecasted Sales by Application (2024-2029)
5.1.3 Global Active Hemostatic Agents Sales Market Share by Application (2018-2029)
5.2 Global Active Hemostatic Agents Revenue by Application
5.2.1 Global Active Hemostatic Agents Historical Revenue by Application (2018-2023)
5.2.2 Global Active Hemostatic Agents Forecasted Revenue by Application (2024-2029)
5.2.3 Global Active Hemostatic Agents Revenue Market Share by Application (2018-2029)
5.3 Global Active Hemostatic Agents Price by Application
5.3.1 Global Active Hemostatic Agents Price by Application (2018-2023)
5.3.2 Global Active Hemostatic Agents Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Active Hemostatic Agents Market Size by Type
6.1.1 US & Canada Active Hemostatic Agents Sales by Type (2018-2029)
6.1.2 US & Canada Active Hemostatic Agents Revenue by Type (2018-2029)
6.2 US & Canada Active Hemostatic Agents Market Size by Application
6.2.1 US & Canada Active Hemostatic Agents Sales by Application (2018-2029)
6.2.2 US & Canada Active Hemostatic Agents Revenue by Application (2018-2029)
6.3 US & Canada Active Hemostatic Agents Market Size by Country
6.3.1 US & Canada Active Hemostatic Agents Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Active Hemostatic Agents Sales by Country (2018-2029)
6.3.3 US & Canada Active Hemostatic Agents Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Active Hemostatic Agents Market Size by Type
7.1.1 Europe Active Hemostatic Agents Sales by Type (2018-2029)
7.1.2 Europe Active Hemostatic Agents Revenue by Type (2018-2029)
7.2 Europe Active Hemostatic Agents Market Size by Application
7.2.1 Europe Active Hemostatic Agents Sales by Application (2018-2029)
7.2.2 Europe Active Hemostatic Agents Revenue by Application (2018-2029)
7.3 Europe Active Hemostatic Agents Market Size by Country
7.3.1 Europe Active Hemostatic Agents Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Active Hemostatic Agents Sales by Country (2018-2029)
7.3.3 Europe Active Hemostatic Agents Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Active Hemostatic Agents Market Size
8.1.1 China Active Hemostatic Agents Sales (2018-2029)
8.1.2 China Active Hemostatic Agents Revenue (2018-2029)
8.2 China Active Hemostatic Agents Market Size by Application
8.2.1 China Active Hemostatic Agents Sales by Application (2018-2029)
8.2.2 China Active Hemostatic Agents Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Active Hemostatic Agents Market Size by Type
9.1.1 Asia Active Hemostatic Agents Sales by Type (2018-2029)
9.1.2 Asia Active Hemostatic Agents Revenue by Type (2018-2029)
9.2 Asia Active Hemostatic Agents Market Size by Application
9.2.1 Asia Active Hemostatic Agents Sales by Application (2018-2029)
9.2.2 Asia Active Hemostatic Agents Revenue by Application (2018-2029)
9.3 Asia Active Hemostatic Agents Sales by Region
9.3.1 Asia Active Hemostatic Agents Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Active Hemostatic Agents Revenue by Region (2018-2029)
9.3.3 Asia Active Hemostatic Agents Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Active Hemostatic Agents Market Size by Type
10.1.1 Middle East, Africa and Latin America Active Hemostatic Agents Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Active Hemostatic Agents Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Active Hemostatic Agents Market Size by Application
10.2.1 Middle East, Africa and Latin America Active Hemostatic Agents Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Active Hemostatic Agents Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Active Hemostatic Agents Sales by Country
10.3.1 Middle East, Africa and Latin America Active Hemostatic Agents Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Active Hemostatic Agents Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Active Hemostatic Agents Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Medtronic Plc.
11.1.1 Medtronic Plc. Company Information
11.1.2 Medtronic Plc. Overview
11.1.3 Medtronic Plc. Active Hemostatic Agents Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Medtronic Plc. Active Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Medtronic Plc. Recent Developments
11.2 Ethicon Inc.
11.2.1 Ethicon Inc. Company Information
11.2.2 Ethicon Inc. Overview
11.2.3 Ethicon Inc. Active Hemostatic Agents Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Ethicon Inc. Active Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Ethicon Inc. Recent Developments
11.3 Pfizer Inc.
11.3.1 Pfizer Inc. Company Information
11.3.2 Pfizer Inc. Overview
11.3.3 Pfizer Inc. Active Hemostatic Agents Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Pfizer Inc. Active Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Pfizer Inc. Recent Developments
11.4 Baxter International Inc.
11.4.1 Baxter International Inc. Company Information
11.4.2 Baxter International Inc. Overview
11.4.3 Baxter International Inc. Active Hemostatic Agents Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Baxter International Inc. Active Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Baxter International Inc. Recent Developments
11.5 CryoLife Inc.
11.5.1 CryoLife Inc. Company Information
11.5.2 CryoLife Inc. Overview
11.5.3 CryoLife Inc. Active Hemostatic Agents Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 CryoLife Inc. Active Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 CryoLife Inc. Recent Developments
11.6 Integra Life Sciences Corporation, etc.
11.6.1 Integra Life Sciences Corporation, etc. Company Information
11.6.2 Integra Life Sciences Corporation, etc. Overview
11.6.3 Integra Life Sciences Corporation, etc. Active Hemostatic Agents Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Integra Life Sciences Corporation, etc. Active Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Integra Life Sciences Corporation, etc. Recent Developments
11.7 Stryker
11.7.1 Stryker Company Information
11.7.2 Stryker Overview
11.7.3 Stryker Active Hemostatic Agents Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Stryker Active Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Stryker Recent Developments
11.8 Biom’up
11.8.1 Biom’up Company Information
11.8.2 Biom’up Overview
11.8.3 Biom’up Active Hemostatic Agents Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Biom’up Active Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Biom’up Recent Developments
11.9 BD
11.9.1 BD Company Information
11.9.2 BD Overview
11.9.3 BD Active Hemostatic Agents Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 BD Active Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 BD Recent Developments
11.10 Johnson & Johnson Services
11.10.1 Johnson & Johnson Services Company Information
11.10.2 Johnson & Johnson Services Overview
11.10.3 Johnson & Johnson Services Active Hemostatic Agents Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Johnson & Johnson Services Active Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Johnson & Johnson Services Recent Developments
11.11 C.R.Bard
11.11.1 C.R.Bard Company Information
11.11.2 C.R.Bard Overview
11.11.3 C.R.Bard Active Hemostatic Agents Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 C.R.Bard Active Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 C.R.Bard Recent Developments
11.12 B. Braun Melsungen AG
11.12.1 B. Braun Melsungen AG Company Information
11.12.2 B. Braun Melsungen AG Overview
11.12.3 B. Braun Melsungen AG Active Hemostatic Agents Sales, Price, Revenue and Gross Margin (2018-2023)
11.12.4 B. Braun Melsungen AG Active Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 B. Braun Melsungen AG Recent Developments
11.13 Z-Medica LLC
11.13.1 Z-Medica LLC Company Information
11.13.2 Z-Medica LLC Overview
11.13.3 Z-Medica LLC Active Hemostatic Agents Sales, Price, Revenue and Gross Margin (2018-2023)
11.13.4 Z-Medica LLC Active Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Z-Medica LLC Recent Developments
11.14 Advanced Medical Solutions Group plc
11.14.1 Advanced Medical Solutions Group plc Company Information
11.14.2 Advanced Medical Solutions Group plc Overview
11.14.3 Advanced Medical Solutions Group plc Active Hemostatic Agents Sales, Price, Revenue and Gross Margin (2018-2023)
11.14.4 Advanced Medical Solutions Group plc Active Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Advanced Medical Solutions Group plc Recent Developments
11.15 GELITA GA
11.15.1 GELITA GA Company Information
11.15.2 GELITA GA Overview
11.15.3 GELITA GA Active Hemostatic Agents Sales, Price, Revenue and Gross Margin (2018-2023)
11.15.4 GELITA GA Active Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 GELITA GA Recent Developments
11.16 Active Hemostatic Agents
11.16.1 Active Hemostatic Agents Company Information
11.16.2 Active Hemostatic Agents Overview
11.16.3 Active Hemostatic Agents Active Hemostatic Agents Sales, Price, Revenue and Gross Margin (2018-2023)
11.16.4 Active Hemostatic Agents Active Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Active Hemostatic Agents Recent Developments
11.17 Warrior Tactical, LLC
11.17.1 Warrior Tactical, LLC Company Information
11.17.2 Warrior Tactical, LLC Overview
11.17.3 Warrior Tactical, LLC Active Hemostatic Agents Sales, Price, Revenue and Gross Margin (2018-2023)
11.17.4 Warrior Tactical, LLC Active Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Warrior Tactical, LLC Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Active Hemostatic Agents Industry Chain Analysis
12.2 Active Hemostatic Agents Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Active Hemostatic Agents Production Mode & Process
12.4 Active Hemostatic Agents Sales and Marketing
12.4.1 Active Hemostatic Agents Sales Channels
12.4.2 Active Hemostatic Agents Distributors
12.5 Active Hemostatic Agents Customers
13 Market Dynamics
13.1 Active Hemostatic Agents Industry Trends
13.2 Active Hemostatic Agents Market Drivers
13.3 Active Hemostatic Agents Market Challenges
13.4 Active Hemostatic Agents Market Restraints
14 Key Findings in The Global Active Hemostatic Agents Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

　

ページTOPに戻る


　

Summary

Active hemostatic agents are standard surgical techniques to manage bleeding from surgical surfaces. Active hemostatic agents are used in a wide variety of surgical settings, and the evolution of this class of surgical tools helps in the progress of active hemostats into present-day surgery and urology, and highlight opportunities for future research.
Global Active Hemostatic Agents market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Active Hemostatic Agents industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2023 to 2029.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Covers:
This report presents an overview of global Active Hemostatic Agents market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Active Hemostatic Agents market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2023 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.

Manufacturers, Type, Application and Regions Listed in the Report:
By Company
Pfizer Inc.
Baxter International Inc.
CryoLife Inc.
Integra Life Sciences Corporation, etc.
Stryker
Biom’up
BD
Johnson & Johnson Services
C.R.Bard
B. Braun Melsungen AG
Z-Medica LLC
Advanced Medical Solutions Group plc
GELITA GA
Active Hemostatic Agents
Warrior Tactical, LLC
Segment by Type
Thrombin based hemostats
Surgical Sealants
Combination Products
Segment by Application
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline
Chapter 1: Product definition, type and application introduction
Chapter 2: Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3: Manufacturers’ sales, revenue and price analysis, including manufacturers’ Active Hemostatic Agents plant distribution, commercial date of Active Hemostatic Agents, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4: Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5: Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6: Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7: Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8: Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9: Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10: Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11: Manufacturers’ outline, covering company’s basic information, major business, Active Hemostatic Agents introduction, etc. Active Hemostatic Agents Sales, Revenue, Price and Gross Margin of each company from 2018 to 2023
Chapter 12: Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13: Market opportunities and challenges analysis
Chapter 14: QYResearch’s Conclusions of Active Hemostatic Agents
Chapter 15: Methodology and Data Sources adopted by QYResearch



ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 Active Hemostatic Agents Product Introduction
1.2 Market by Type
1.2.1 Global Active Hemostatic Agents Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Thrombin based hemostats
1.2.3 Surgical Sealants
1.2.4 Combination Products
1.3 Market by Application
1.3.1 Global Active Hemostatic Agents Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Specialty Clinics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Active Hemostatic Agents Sales Estimates and Forecasts 2018-2029
2.2 Global Active Hemostatic Agents Revenue by Region
2.2.1 Global Active Hemostatic Agents Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Active Hemostatic Agents Revenue by Region (2018-2023)
2.2.3 Global Active Hemostatic Agents Revenue by Region (2024-2029)
2.2.4 Global Active Hemostatic Agents Revenue Market Share by Region (2018-2029)
2.3 Global Active Hemostatic Agents Sales Estimates and Forecasts 2018-2029
2.4 Global Active Hemostatic Agents Sales by Region
2.4.1 Global Active Hemostatic Agents Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Active Hemostatic Agents Sales by Region (2018-2023)
2.4.3 Global Active Hemostatic Agents Sales by Region (2024-2029)
2.4.4 Global Active Hemostatic Agents Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Active Hemostatic Agents Sales by Manufacturers
3.1.1 Global Active Hemostatic Agents Sales by Manufacturers (2018-2023)
3.1.2 Global Active Hemostatic Agents Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Active Hemostatic Agents in 2022
3.2 Global Active Hemostatic Agents Revenue by Manufacturers
3.2.1 Global Active Hemostatic Agents Revenue by Manufacturers (2018-2023)
3.2.2 Global Active Hemostatic Agents Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Active Hemostatic Agents Revenue in 2022
3.3 Global Key Players of Active Hemostatic Agents, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Active Hemostatic Agents Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Active Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Active Hemostatic Agents, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Active Hemostatic Agents, Product Offered and Application
3.8 Global Key Manufacturers of Active Hemostatic Agents, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Active Hemostatic Agents Sales by Type
4.1.1 Global Active Hemostatic Agents Historical Sales by Type (2018-2023)
4.1.2 Global Active Hemostatic Agents Forecasted Sales by Type (2024-2029)
4.1.3 Global Active Hemostatic Agents Sales Market Share by Type (2018-2029)
4.2 Global Active Hemostatic Agents Revenue by Type
4.2.1 Global Active Hemostatic Agents Historical Revenue by Type (2018-2023)
4.2.2 Global Active Hemostatic Agents Forecasted Revenue by Type (2024-2029)
4.2.3 Global Active Hemostatic Agents Revenue Market Share by Type (2018-2029)
4.3 Global Active Hemostatic Agents Price by Type
4.3.1 Global Active Hemostatic Agents Price by Type (2018-2023)
4.3.2 Global Active Hemostatic Agents Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Active Hemostatic Agents Sales by Application
5.1.1 Global Active Hemostatic Agents Historical Sales by Application (2018-2023)
5.1.2 Global Active Hemostatic Agents Forecasted Sales by Application (2024-2029)
5.1.3 Global Active Hemostatic Agents Sales Market Share by Application (2018-2029)
5.2 Global Active Hemostatic Agents Revenue by Application
5.2.1 Global Active Hemostatic Agents Historical Revenue by Application (2018-2023)
5.2.2 Global Active Hemostatic Agents Forecasted Revenue by Application (2024-2029)
5.2.3 Global Active Hemostatic Agents Revenue Market Share by Application (2018-2029)
5.3 Global Active Hemostatic Agents Price by Application
5.3.1 Global Active Hemostatic Agents Price by Application (2018-2023)
5.3.2 Global Active Hemostatic Agents Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Active Hemostatic Agents Market Size by Type
6.1.1 US & Canada Active Hemostatic Agents Sales by Type (2018-2029)
6.1.2 US & Canada Active Hemostatic Agents Revenue by Type (2018-2029)
6.2 US & Canada Active Hemostatic Agents Market Size by Application
6.2.1 US & Canada Active Hemostatic Agents Sales by Application (2018-2029)
6.2.2 US & Canada Active Hemostatic Agents Revenue by Application (2018-2029)
6.3 US & Canada Active Hemostatic Agents Market Size by Country
6.3.1 US & Canada Active Hemostatic Agents Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Active Hemostatic Agents Sales by Country (2018-2029)
6.3.3 US & Canada Active Hemostatic Agents Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Active Hemostatic Agents Market Size by Type
7.1.1 Europe Active Hemostatic Agents Sales by Type (2018-2029)
7.1.2 Europe Active Hemostatic Agents Revenue by Type (2018-2029)
7.2 Europe Active Hemostatic Agents Market Size by Application
7.2.1 Europe Active Hemostatic Agents Sales by Application (2018-2029)
7.2.2 Europe Active Hemostatic Agents Revenue by Application (2018-2029)
7.3 Europe Active Hemostatic Agents Market Size by Country
7.3.1 Europe Active Hemostatic Agents Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Active Hemostatic Agents Sales by Country (2018-2029)
7.3.3 Europe Active Hemostatic Agents Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Active Hemostatic Agents Market Size
8.1.1 China Active Hemostatic Agents Sales (2018-2029)
8.1.2 China Active Hemostatic Agents Revenue (2018-2029)
8.2 China Active Hemostatic Agents Market Size by Application
8.2.1 China Active Hemostatic Agents Sales by Application (2018-2029)
8.2.2 China Active Hemostatic Agents Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Active Hemostatic Agents Market Size by Type
9.1.1 Asia Active Hemostatic Agents Sales by Type (2018-2029)
9.1.2 Asia Active Hemostatic Agents Revenue by Type (2018-2029)
9.2 Asia Active Hemostatic Agents Market Size by Application
9.2.1 Asia Active Hemostatic Agents Sales by Application (2018-2029)
9.2.2 Asia Active Hemostatic Agents Revenue by Application (2018-2029)
9.3 Asia Active Hemostatic Agents Sales by Region
9.3.1 Asia Active Hemostatic Agents Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Active Hemostatic Agents Revenue by Region (2018-2029)
9.3.3 Asia Active Hemostatic Agents Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Active Hemostatic Agents Market Size by Type
10.1.1 Middle East, Africa and Latin America Active Hemostatic Agents Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Active Hemostatic Agents Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Active Hemostatic Agents Market Size by Application
10.2.1 Middle East, Africa and Latin America Active Hemostatic Agents Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Active Hemostatic Agents Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Active Hemostatic Agents Sales by Country
10.3.1 Middle East, Africa and Latin America Active Hemostatic Agents Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Active Hemostatic Agents Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Active Hemostatic Agents Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Medtronic Plc.
11.1.1 Medtronic Plc. Company Information
11.1.2 Medtronic Plc. Overview
11.1.3 Medtronic Plc. Active Hemostatic Agents Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Medtronic Plc. Active Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Medtronic Plc. Recent Developments
11.2 Ethicon Inc.
11.2.1 Ethicon Inc. Company Information
11.2.2 Ethicon Inc. Overview
11.2.3 Ethicon Inc. Active Hemostatic Agents Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Ethicon Inc. Active Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Ethicon Inc. Recent Developments
11.3 Pfizer Inc.
11.3.1 Pfizer Inc. Company Information
11.3.2 Pfizer Inc. Overview
11.3.3 Pfizer Inc. Active Hemostatic Agents Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Pfizer Inc. Active Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Pfizer Inc. Recent Developments
11.4 Baxter International Inc.
11.4.1 Baxter International Inc. Company Information
11.4.2 Baxter International Inc. Overview
11.4.3 Baxter International Inc. Active Hemostatic Agents Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Baxter International Inc. Active Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Baxter International Inc. Recent Developments
11.5 CryoLife Inc.
11.5.1 CryoLife Inc. Company Information
11.5.2 CryoLife Inc. Overview
11.5.3 CryoLife Inc. Active Hemostatic Agents Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 CryoLife Inc. Active Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 CryoLife Inc. Recent Developments
11.6 Integra Life Sciences Corporation, etc.
11.6.1 Integra Life Sciences Corporation, etc. Company Information
11.6.2 Integra Life Sciences Corporation, etc. Overview
11.6.3 Integra Life Sciences Corporation, etc. Active Hemostatic Agents Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Integra Life Sciences Corporation, etc. Active Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Integra Life Sciences Corporation, etc. Recent Developments
11.7 Stryker
11.7.1 Stryker Company Information
11.7.2 Stryker Overview
11.7.3 Stryker Active Hemostatic Agents Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Stryker Active Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Stryker Recent Developments
11.8 Biom’up
11.8.1 Biom’up Company Information
11.8.2 Biom’up Overview
11.8.3 Biom’up Active Hemostatic Agents Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Biom’up Active Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Biom’up Recent Developments
11.9 BD
11.9.1 BD Company Information
11.9.2 BD Overview
11.9.3 BD Active Hemostatic Agents Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 BD Active Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 BD Recent Developments
11.10 Johnson & Johnson Services
11.10.1 Johnson & Johnson Services Company Information
11.10.2 Johnson & Johnson Services Overview
11.10.3 Johnson & Johnson Services Active Hemostatic Agents Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Johnson & Johnson Services Active Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Johnson & Johnson Services Recent Developments
11.11 C.R.Bard
11.11.1 C.R.Bard Company Information
11.11.2 C.R.Bard Overview
11.11.3 C.R.Bard Active Hemostatic Agents Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 C.R.Bard Active Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 C.R.Bard Recent Developments
11.12 B. Braun Melsungen AG
11.12.1 B. Braun Melsungen AG Company Information
11.12.2 B. Braun Melsungen AG Overview
11.12.3 B. Braun Melsungen AG Active Hemostatic Agents Sales, Price, Revenue and Gross Margin (2018-2023)
11.12.4 B. Braun Melsungen AG Active Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 B. Braun Melsungen AG Recent Developments
11.13 Z-Medica LLC
11.13.1 Z-Medica LLC Company Information
11.13.2 Z-Medica LLC Overview
11.13.3 Z-Medica LLC Active Hemostatic Agents Sales, Price, Revenue and Gross Margin (2018-2023)
11.13.4 Z-Medica LLC Active Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Z-Medica LLC Recent Developments
11.14 Advanced Medical Solutions Group plc
11.14.1 Advanced Medical Solutions Group plc Company Information
11.14.2 Advanced Medical Solutions Group plc Overview
11.14.3 Advanced Medical Solutions Group plc Active Hemostatic Agents Sales, Price, Revenue and Gross Margin (2018-2023)
11.14.4 Advanced Medical Solutions Group plc Active Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Advanced Medical Solutions Group plc Recent Developments
11.15 GELITA GA
11.15.1 GELITA GA Company Information
11.15.2 GELITA GA Overview
11.15.3 GELITA GA Active Hemostatic Agents Sales, Price, Revenue and Gross Margin (2018-2023)
11.15.4 GELITA GA Active Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 GELITA GA Recent Developments
11.16 Active Hemostatic Agents
11.16.1 Active Hemostatic Agents Company Information
11.16.2 Active Hemostatic Agents Overview
11.16.3 Active Hemostatic Agents Active Hemostatic Agents Sales, Price, Revenue and Gross Margin (2018-2023)
11.16.4 Active Hemostatic Agents Active Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Active Hemostatic Agents Recent Developments
11.17 Warrior Tactical, LLC
11.17.1 Warrior Tactical, LLC Company Information
11.17.2 Warrior Tactical, LLC Overview
11.17.3 Warrior Tactical, LLC Active Hemostatic Agents Sales, Price, Revenue and Gross Margin (2018-2023)
11.17.4 Warrior Tactical, LLC Active Hemostatic Agents Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Warrior Tactical, LLC Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Active Hemostatic Agents Industry Chain Analysis
12.2 Active Hemostatic Agents Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Active Hemostatic Agents Production Mode & Process
12.4 Active Hemostatic Agents Sales and Marketing
12.4.1 Active Hemostatic Agents Sales Channels
12.4.2 Active Hemostatic Agents Distributors
12.5 Active Hemostatic Agents Customers
13 Market Dynamics
13.1 Active Hemostatic Agents Industry Trends
13.2 Active Hemostatic Agents Market Drivers
13.3 Active Hemostatic Agents Market Challenges
13.4 Active Hemostatic Agents Market Restraints
14 Key Findings in The Global Active Hemostatic Agents Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（その他）の最新刊レポート

QYResearch 社の最新刊レポート

本レポートと同じKEY WORD（agents）の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/10/08　10:26

148.90 円

163.91 円

197.75 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.